Renal Cell Carcinoma

albumin test

CONUT Score Predicts Clinical Outcomes in Patients with Advanced RCC Receiving Nivolumab

The controlling nutritional status (CONUT) score measures albumin, lymphocytes, and total cholesterol to assess nutritional health. A study evaluated the use of the CONUT...
Medical Vials and Syringe Backgrounds

An Assessment of Pretreated Patients with Metastatic RCC Who Receive Nivolumab

A retrospective study examined the correlation between nivolumab in pretreated patients with metastatic renal cell carcinoma (RCC) and clinicopathological features, metastatic sites, and clinical...

The Multifaceted Relationship Between Five-Year Survival of Clear Cell RCC and Race

A study evaluated the correlation between race and five-year survival in patients with clear cell renal cell carcinoma (ccRCC). The researchers did not observe...

An Assessment of Improvements in Metastatic RCC Outcomes Over Four Decades Using Real-World Data

Outcomes for metastatic renal cell carcinoma (RCC) have improved over a 40-year period with successive systemic therapy paradigms, according to a retrospective study. Patients (n=576)...

Using the Comprehensive Geriatric Assessment to Predict Adverse Outcomes in Metastatic RCC

A retrospective study measured the prognostic value of the Comprehensive Geriatric Assessment (CGA) in older patients with metastatic renal cell carcinoma (RCC) treated with...

RCC Treatment During the COVID-19 Pandemic: A Patient Perspective

The COVID-19 pandemic has impacted treatment decisions for providers. However, it is the responsibility of the patient to make final treatment decisions. A study...

Racial Disparities in RCC Overall Survival

Despite presenting at a younger age and with lower-stage disease, Black  patients with renal cell carcinoma (RCC) have poorer overall survival (OS) than White...

Journal Reading List

Advertisement
Advertisement
click me